Y-27632 dihydrochloride: Selective ROCK1/2 Inhibitor for Cytoskeletal and Cancer Research

Executive Summary: Y-27632 dihydrochloride is a small-molecule inhibitor that selectively targets ROCK1 and ROCK2 with IC₅₀ values of 140 nM and Ki of 300 nM, respectively, showing over 200-fold selectivity versus other kinases (APExBIO). It disrupts Rho-mediated stress fiber formation, impairs cytokinesis, and modulates the G1/S cell cycle transition in vitro (Hinderling et al. 2025). The compound is highly soluble in DMSO, ethanol, and water under specified conditions and can be stored at −20°C for several months in stock form. Y-27632 is widely used to enhance stem cell viability, reduce prostatic smooth muscle cell proliferation, and suppress tumor invasion in mouse models. Its robust selectivity and reproducibility make it a standard tool in Rho/ROCK pathway studies and cancer research.

Biological Rationale

Rho-associated protein kinases (ROCK1 and ROCK2) are central effectors in the Rho/ROCK signaling pathway, modulating actin cytoskeleton dynamics, cell contractility, and cell cycle progression. Aberrant ROCK activity is implicated in pathological conditions, including tumor invasion, fibrosis, and abnormal smooth muscle proliferation (Hinderling et al. 2025). Y-27632 dihydrochloride, supplied by APExBIO, offers targeted, reversible inhibition of ROCK kinases with minimal off-target effects, enabling precise mechanistic investigations in both basic and translational research (APExBIO product page).

Mechanism of Action of Y-27632 dihydrochloride

Y-27632 dihydrochloride is a cell-permeable inhibitor that binds the ATP-binding site within the catalytic domain of ROCK1 (IC₅₀ ≈ 140 nM) and ROCK2 (Ki ≈ 300 nM), resulting in potent inhibition of kinase activity. This selectivity exceeds 200-fold compared to kinases such as PKC, cAMP-dependent protein kinase, MLCK, and PAK. Inhibition of ROCK disrupts phosphorylation of downstream targets, including myosin light chain (MLC) and LIM kinase, leading to loss of actin stress fibers, decreased cell contractility, and impaired cytokinesis. The compound also impedes Rho-mediated signaling, modulating cell cycle progression from G1 to S phase and influencing cellular morphology and motility (Hinderling et al. 2025). These actions position Y-27632 as a benchmark tool for dissecting the molecular underpinnings of cytoskeletal architecture and cellular proliferation.

Evidence & Benchmarks

• Y-27632 inhibits ROCK1 with an IC₅₀ of 140 nM under in vitro kinase assay conditions (buffered at pH 7.4, 25°C) (APExBIO).
• It demonstrates a Ki of 300 nM for ROCK2, providing quantitative selectivity in enzymatic assays (APExBIO).
• Displays >200-fold selectivity over PKC, cAMP-dependent protein kinase, MLCK, and PAK in kinase profiling (in vitro, 10 μM substrate, 30 min incubation) (APExBIO).
• Reduces prostatic smooth muscle cell proliferation in a concentration-dependent manner (in vitro, 0.1–10 μM, 48 h) (Hinderling et al. 2025).
• Suppresses tumor invasion and metastasis in mouse models (in vivo, 10 mg/kg/day, 14–21 days) (Hinderling et al. 2025).
• Enhances viability and expansion of human pluripotent stem cells in feeder-free culture (in vitro, 10 μM, 37°C) (Houston Biochem review).
• Disrupts Rho-mediated actin stress fiber formation in fibroblasts (in vitro, 2 μM, 4 h incubation) (Hinderling et al. 2025).

Applications, Limits & Misconceptions

Y-27632 dihydrochloride is a pivotal tool in multiple research domains:

• Cytoskeletal studies: Used to dissect actin filament dynamics and cellular contractility (see also: X-Press Tag article; this article provides updated solubility and selectivity benchmarks).
• Stem cell culture: Enhances survival and expansion of human pluripotent and neural stem cells (see: Houston Biochem review; here, we clarify dose-response and storage conditions).
• Tumor biology: Inhibits tumor cell invasion and metastasis in preclinical models (see: Ski-606 article; this review incorporates new in vivo data and protocol recommendations).
• Cell proliferation assays: Serves as a reference compound to assess the role of ROCK in cell cycle transitions.
• Microfabrication and mechanotransduction: Used to study cell response to physical microenvironments in engineered devices (Hinderling et al. 2025).

Common Pitfalls or Misconceptions

• Non-specific kinase inhibition: At concentrations above 10 μM, Y-27632 may inhibit kinases beyond ROCK1/2; verify dose-dependent specificity for each cell type.
• Long-term solution stability: Prolonged storage of aqueous or DMSO solutions (>1 month at 4°C) leads to degradation; always prepare fresh aliquots (APExBIO).
• In vivo non-equivalence: Efficacy in mouse models may not translate directly to other species due to pharmacokinetic differences.
• Cell-type dependency: Not all cell types respond identically to ROCK inhibition; assay optimization is required.
• Mechanistic oversimplification: While Y-27632 blocks Rho-mediated pathways, not all Rho functions are ROCK-dependent; interpret results within pathway context.

Workflow Integration & Parameters

Solubility: Y-27632 is soluble at ≥111.2 mg/mL in DMSO, ≥17.57 mg/mL in ethanol, and ≥52.9 mg/mL in water. To prepare stock solutions, dissolve the compound at room temperature, warming to 37°C or using an ultrasonic bath if needed. Store solid at 4°C (desiccated) or below; for stock solutions, freeze at −20°C and avoid repeated freeze-thaw cycles (APExBIO).

Recommended concentrations: In vitro experiments typically use 1–10 μM; in vivo studies, 1–10 mg/kg/day (adjust per model). For cell proliferation or cytoskeletal assays, titrate concentration and exposure time based on cell line and endpoint (see: Papilostatin-2 protocol guide; this article provides additional storage and preparation insights).

Compatibility: Y-27632 is suitable for use in microfabricated environments and high-content imaging, enabling robust mechanotransduction and migration studies (Hinderling et al. 2025).

Conclusion & Outlook

Y-27632 dihydrochloride remains a gold-standard, cell-permeable ROCK1/2 inhibitor with broad applications in cancer, stem cell, and cytoskeletal research. Its selectivity, solubility, and robust performance support reproducible data across diverse biological systems. When sourced from APExBIO, the A3008 kit offers validated quality and batch consistency. Future research will extend its use in engineered microenvironments and precision medicine. For detailed mechanistic reviews, see our advanced insights article (this review provides new in vivo and microfabrication data).

For ordering and technical resources, visit the Y-27632 dihydrochloride product page.